Overall Technical outlook

Price Summary

On 2025-12-10, SUNPHARMA's stock started at 1787.9, reached a high of 1791.7, fell to 1767.9, and ended -0.13% down at 1785.5, with 2321740 shares traded.
Over the past year, the stock's highest price was 1889.95, and its lowest was 1563.3.
The future price of SUNPHARMA is anticipated to range from 1570.0 to 2450.0, with an expected mean price of 1948.9736, according to the recommendations of 38 analysts.

Technicals

Support and Resistance: At 1785.5, the price for SUNPHARMA is supported at 1777.4 and resisted at 1806.7. This indicates a trading range where 1777.4 serves as a support level, potentially preventing further decline, while 1806.7 could limit upward movement.
SUNPHARMA supportResistance 937f5c
Support/Resistance for SUNPHARMA


Aroon: The AROON is currently in a neutral position for Sun Pharmaceutical Industries Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
SUNPHARMA aroon 937f5c
Aroon chart for Sun Pharmaceutical Industries Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
SUNPHARMA bbands 937f5c
Bolinger Bands chart for Sun Pharmaceutical Industries Limited


Parabolic SAR: The PSAR remains in a bearish mode, setting a resistance level that could impede any upward movement. This resistance indicates that the market may continue to face bearish pressure, with limited potential for breaking higher.
SUNPHARMA psar 937f5c
Parabolic Stop and Reverse chart for Sun Pharmaceutical Industries Limited


Stochastic: The STOCHASTIC is in a neutral stance for SUNPHARMA, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
SUNPHARMA stoch 937f5c
Stochastic chart for Sun Pharmaceutical Industries Limited


Tripple Moving Agerage: The 20, 50, and 100 moving averages are aligned bearishly, signaling a downtrend. However, the slopes of the 20 and 50 SMAs are starting to waver, indicating that this bearish momentum might be losing strength. This could suggest an upcoming shift towards bullish price action, as the market's current downward trend may be approaching a reversal, potentially leading to a new upward move.
SUNPHARMA trippleSMA 937f5c
Tripple SMA chart for Sun Pharmaceutical Industries Limited


A company's technical data, including stock price and trading volume, can provide valuable insights when considered alongside its fundamentals. These include financial performance, market share, and growth strategy, as well as broader industry dynamics. Examining these factors helps investors or analysts make more informed decisions, as the company's fundamentals offer context for understanding how and why certain technical patterns may emerge in the market.